High Tower Advisors, LLC Athira Pharma, Inc. Transaction History
High Tower Advisors, LLC
- $64.2 Billion
- Q2 2024
A detailed history of High Tower Advisors, LLC transactions in Athira Pharma, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 12,468 shares of ATHA stock, worth $6,608. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,468
Previous 12,468
-0.0%
Holding current value
$6,608
Previous $34,000
2.94%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ATHA
# of Institutions
74Shares Held
22.8MCall Options Held
73.4KPut Options Held
97.8K-
Perceptive Advisors LLC New York, NY5.4MShares$2.86 Million0.41% of portfolio
-
Baker Bros. Advisors LP New York, NY3.15MShares$1.67 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.63MShares$866,2490.0% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.49MShares$791,1792.57% of portfolio
-
Simplify Asset Management Inc. New York, NY1.49MShares$791,1790.29% of portfolio
About Athira Pharma, Inc.
- Ticker ATHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,817,700
- Market Cap $20M
- Description
- Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...